Amylin's long-delayed diabetes drug gets FDA nod

January 27, 2012, 4:41 am by Associated Press Healthwire

WASHINGTON (AP) -- Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old product, Byetta....

Read the full article

More from Associated Press Healthwire

Doctors: Myanmar desperate for HIV and TB drugs
Associated Press Healthwire : February 22, 2012, 7:30 am
BANGKOK (AP) -- Some 85,000 HIV-infected people in Myanmar are not getting treatment due to a lack of funding, despite renewed international engagement with the government amid a

Study: Colonoscopy cuts colon cancer death risk
Associated Press Healthwire : February 22, 2012, 5:18 am
LOS ANGELES (AP) -- Millions of people have endured a colonoscopy, believing the dreaded exam may help keep them from dying of colon cancer. For the first time,

Common prenatal tests become campaign issue
Associated Press Healthwire : February 22, 2012, 4:56 am
WASHINGTON (AP) -- First birth control, now prenatal testing? Once again a fact of life for many American women has become a jarring issue in the presidential race....

FDA panel backs previously rejected obesity pill
Associated Press Healthwire : February 22, 2012, 4:28 am
SILVER SPRING, Md. (AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a

FDA: New suppliers to ease 2 cancer drug shortages
Associated Press Healthwire : February 21, 2012, 12:03 pm
TRENTON, N.J. (AP) -- Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being